The Use of MR-Guided Radiation Therapy for Pancreatic Cancer. Semin Radiat Oncol 2024 Jan;34(1):23-35
Date
12/18/2023Pubmed ID
38105090DOI
10.1016/j.semradonc.2023.10.002Scopus ID
2-s2.0-85178168607 (requires institutional sign-in at Scopus site) 1 CitationAbstract
The introduction of online adaptive magnetic resonance (MR)-guided radiation therapy (RT) has enabled safe treatment of pancreatic cancer with ablative doses. The aim of this review is to provide a comprehensive overview of the current literature on the use and clinical outcomes of MR-guided RT for treatment of pancreatic cancer. Relevant outcomes included toxicity, tumor response, survival and quality of life. The results of these studies support further investigation of the effectiveness of ablative MR-guided SBRT as a low-toxic, minimally-invasive therapy for localized pancreatic cancer in prospective clinical trials.
Author List
Daamen LA, Parikh PJ, Hall WAAuthor
William Adrian Hall MD Professor in the Radiation Oncology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
HumansMagnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Pancreatic Neoplasms
Prospective Studies
Quality of Life
Radiosurgery
